glp 1 blindness study π Optometrists are warning GLP-1 drugs may pose these types of rare risks π β¬οΈ Details in comments The protective role of GLP-1
Description
Could GLP-1s help as part of an integrative strategy
Discuss timing with your prescriber, especially for medications with narrow therapeutic windows
As weight loss drugs, semaglutide was approved as Wegovy in 2021 and tirzepatide was approved as Zepbound in 2023
However, previous studies on the extent of drug absorption (area under the curve [AUC]) in patients with other gastrointestinal motility disorders reported conflicting results [8, 9]
10.1002/14651858.CD003824.pub2 [DOI] [PMC free article] [PubMed] [Google Scholar] 57
[DOI] [PubMed] [Google Scholar] 103.Marso SP, et al
